Massive Transfusion
6
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Impact of Traumatic Brain Injury on Hemodynamic Instability in Patients With Blunt Bowel and Mesenteric Injuries
"ADE Fibrinogen/RBC" Ratio on Mortality and Outcome in Massive Transfusion Patients
A Nomogram Predicting the Risk of High-dose Transfusion in Non-cardiac Surgery
Prediction of Massive Transfusion in Trauma Patients
Australian and New Zealand Massive Transfusion Registry
Evaluating of the Hospital Universitario de Canarias Massive Transfusion Protocol